He nui nā hoʻoweliweli maikaʻi o ka hauʻoli
ʻO nā hana e hōʻemi i ka hoʻoiliʻana o nā kahu hipa-cov-2 i kūpono i ka hoʻemiʻana i ka hoʻoiliʻana i nā maʻi hanu likeʻole. E like me ka nui o nā'āina e hōʻemi ai i ka hoʻohanaʻana o kēlā mau hana,ʻo Sars-Cov-2 e hoʻopili me nā maʻi'ē aʻe, ka hoʻonuiʻana i ka hopena o nāʻano o nā co-maʻi.
ʻO nā poʻe loea i wānana i laila he mau triple epidemic ma kēia hoʻoilo ma muli o ka huiʻana o nā maʻi maʻamau ʻO ka nui o nā hihia o nā flu a me RsV i kēia makahiki ke kiʻekiʻe aʻe ma mua o ka manawa like i nā makahiki i hala. ʻO nāʻano hou hou Ba.4 a me Ba.5 o ka Sars-Cov-2 Virus ua hoʻohui hou i ka Epidemic i hoʻokahi manawa.
I ka "World Worth Day 2022 symposium" ma Nowemapa 4, 2022, Zhong Nation i ka hale o ke kula."Ke kū nei ke ao nei i ka hopena o ka hopena o nā cirdmics o nā car-cov-2 viempic a me ka hopena hopena." Ua kuhikuhiʻo ia, "ʻO ia ka hoʻoilo, pono mau ia e hoʻoikaika i kaʻimiʻana i nā pilikiaʻepekema ma ka paleʻana a me ka kāohi."Wahi a nā helu helu o mākou CDC, ka nui o nā kipa o ka hale hoʻokipa no nā maʻi hanu maʻAmelika Hui PūʻIa o nāʻAmelika Hui PūʻIa a me nā maʻi hoʻohālikelike hou.
ʻO ka hoʻonuiʻana i nā huakaʻi RSV a me nā hale kūʻai o RSV-RSV-pili i nā hale kūʻai o nā US. I kēia wā, ua hōʻea ka nui o nā hihia SMV i loko o mākou i hōʻea i mākou i ka loiloi kiʻekiʻe ma nā makahiki 25, ua paniʻia kekahi mau kula.
Ua hakiʻia ka hopena Orideenza ma Australia ma Australia maʻApelila i kēia makahiki a mau loa no 4 mau mahina. E like me Kepakemapa 25, aia he 224,4,5,5,5,5,5,5,5,5,5,5,5,5,5,5,S i hoʻopaʻaʻia i nā hihia o ka hopena E hoʻohālikelikeʻia, ma lalo o nā kahu hipa-cers-cone-2 brus-2 mau hana e pili ana i nā hihia he 2120 aʻoi aku ka liʻiliʻi ma mua o 100
ʻO ka hōʻikeʻo 35thly Express o China Offenza Center ma 2022 e hōʻike ana i nāʻano o nāʻano he nui ma mua o ka pae mua. E like me ka waena waena, ua hōʻikeʻia ka nui o nā hihia i nā hihia i hōʻikeʻia ma Guangzhou i hoʻonuiʻia e nā makahiki i hala.
Ua hoʻokuʻuʻia nā hopena o kahi haʻawina o kahi kula 11-o keʻano o ka Global Global Global maʻOkakopa e hōʻike ana i ka hopena o ka nui o ka lehulehu. Ua wānana nō hoʻiʻo ia e hoʻonuiʻia ka piak
212,466 Nā pākeke me nā wahineʻo Sars-COV-2 i loaʻa i ka haukapila. Ua hoʻopaʻaʻia nā hoʻokolohua no nā c -heral collaral collaral no 6,965 mau maʻi me nā mea maʻiʻo Sars-Cov-2. Uaʻikeʻia nā maʻi maʻi viral ma 583 (820 (4%) nā maʻi maʻi maʻi, a loaʻa nā maʻi maʻi maʻi maʻi.
Ua pili pū nā maʻi me nā maʻi me nā maʻi maʻi i hoʻonuiʻia me ka hoʻonuiʻana o ka loaʻaʻana o nā mea kūʻai mechanical mechanivation me nā mono-cir-2 mono-maʻi. ʻO Sars-Cov-2 mau co-thefultions me nā maʻi maʻi maʻi a me nā adoevorants a me nā adoevoiruss i kēlā me kēia e pili ana i ka hopena o ka make. ʻO ka a iʻole no keʻano o ka invasalical mechanical i keʻano o ka mana o ka mana. ʻO ka nui a iʻole no ka makeʻana o ka haukapila i loko o nā mea maʻi maʻi che-infealza c-iffenza he 2.35 (95% ci 1.07-5.5.5. ʻO ka nui a iʻole no ka makeʻana o ka haukapila ma nā maʻi ADENOVIRUS CO-iffect
ʻO nā hopena o kēia noiʻi e haʻi pololei iā mākou e pili ana i ka maʻi cor-chers-cars-2 mau virus a me nā maʻi maʻi a me nā maʻi maʻi a me nā maʻi maʻi maʻi.
Ma mua o ka pukaʻana o nā kahu hipa-cov-2, nā hōʻailona o nāʻano hanu likeʻole likeʻole, akā heʻokoʻa nā ala lapaʻau. Ināʻaʻole e hilinaʻi nā mea maʻi i nā hōʻike he nui, e hoʻonui houʻia ka mālamaʻana o nā maʻi hanu o ka hanuʻana, a e hoʻopau maʻalahi ia i nā kumuwaiwai kiʻekiʻe i ka wā kiʻekiʻe. No laila,ʻo nā hoʻokolohua hui nui e pāʻani i kahi hana koʻikoʻi ma keʻano he maʻi maʻi maʻi ma nā maʻi maʻi ma nā maʻi he nui o ka maʻi swab.
ʻO Macro & Micro-Micro-Cover-Cov-COV-2 refpiratory lehulehu
ʻO Macro & Micro-Micro-Micro e like me nā mea e like me ka nui o ka fluorescent Loaʻa nā huahana āpau i loaʻa i ka hōʻoiaʻo EU CE CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO COLI
1
Kaohi kūloko: Ke nānā pihaʻana i ke kaʻina hoʻokolohua e hōʻoia i ka maikaʻi o nā hoʻokolohua.
Maffienv nui:ʻO ka PCR i ka PCR i ka manawa maʻamau i loaʻa i nā mea likeʻole no ka SERS-COV-2, Fluplarma Phoemani
Nui loa: 300 Copies / ML Na Keiki-Cirst-2, 500oppiies / ML No Ka wahine Precus, 500coies / ML Forforenzae Pahu 5
2. Sars-Cov-2 / Offienza A / Octienza b nuckac Acticad Urdid Detain Cat (Fluerescence PCR)
Kaohi kūloko: Ke nānā pihaʻana i ke kaʻina hoʻokolohua e hōʻoia i ka maikaʻi o nā hoʻokolohua.
Maffienv nui:ʻIkeʻo Pc Score Profes
Nui loa: 300 Copies / ML o Sers-COV-COV-2,500COPIES / ML o LFV A a me 500copies / ML o LFV B.
3.ʻO Sars-Cov-2, Pule A me ka hoʻonaninaniʻo a me ka hoʻonaninanima b antienzatograp (ImmunochHominography)
Maʻalahi e hoʻohana
ʻO ke kaʻa kaʻawale o ka lumi a waiho i ka 4-30 ° ° ℃
ʻO ke kū nui kiʻekiʻe
| Hua waihona | Kaoaohai |
| ʻO ka manawa maoli fluorescent RT-PCR no ka nānāʻana iʻeono mauʻano o nā pathogens | 20 mau hōʻike / kit,48 mau hōʻike / kit,50 mau hōʻike / kit |
| ʻO Sars-Cov-2 / Octienza A / Octienza B Niacclec Acpicance Econnicance Kit (Fluorescence PCR) | 48 mau hōʻike / kit,50 mau hōʻike / kit |
| Sars-Cov-2, Hoʻohui i nā'ōnaehana i huiʻia i ka 3 (Immunochhunography) | 1 Hōʻike / Kit,20 mau hōʻike / kit |
Post Time: Def-09-2022